Citation: Rm. Reilly et J. Gariepy, FACTORS INFLUENCING THE SENSITIVITY OF TUMOR IMAGING WITH A RECEPTOR-BINDING RADIOPHARMACEUTICAL (VOL 39, PG 1036, 1998), The Journal of nuclear medicine, 39(9), 1998, pp. 1651-1651
Citation: Rm. Reilly et J. Gariepy, FACTORS INFLUENCING THE SENSITIVITY OF TUMOR IMAGING WITH A RECEPTOR-BINDING RADIOPHARMACEUTICAL, The Journal of nuclear medicine, 39(6), 1998, pp. 1036-1043
Citation: Rm. Reilly et al., A COMPARISON OF THE NATIVE PEPTIDE LIGAND AND A MONOCLONAL-ANTIBODY (MAB) AGAINST THE EPIDERMAL GROWTH-FACTOR RECEPTOR (EGFR) FOR IMAGING HUMAN BREAST-CANCER, The Journal of nuclear medicine, 39(5), 1998, pp. 296-296
Authors:
DESSUREAULT S
KOVEN I
REILLY RM
COUTURE J
SCHMOCKER B
DAMANI M
KIRSH J
ICHISE M
SIDLOFSKY S
MCEWAN AJB
BONIFACE G
STERN H
GALLINGER S
Citation: S. Dessureault et al., PREOPERATIVE ASSESSMENT OF AXILLARY LYMPH-NODE STATUS IN PATIENTS WITH BREAST ADENOCARCINOMA USING INTRAVENOUS (99M)TECHNETIUM MAB-170H.82 (TRUSCINT(R)AD(TM)), Breast cancer research and treatment, 45(1), 1997, pp. 29-37
Citation: Rj. Domingo et Rm. Reilly, PRE-TARGETING WITH STREPTAVIDIN-CC49 MONOCLONAL-ANTIBODY AND IN-111 Y-90 DOTA-BIOTIN/, The Journal of nuclear medicine, 38(5), 1997, pp. 806-806
Citation: S. Remy et al., A NEW RADIOLIGAND FOR THE EPIDERMAL GROWTH-FACTOR RECEPTOR - IN-111 LABELED HUMAN EPIDERMAL GROWTH-FACTOR DERIVATIZED WITH A BIFUNCTIONAL METAL-CHELATING PEPTIDE (VOL 6, PG 686, 1995), Bioconjugate chemistry, 7(6), 1996, pp. 721-721
Citation: Tm. Alvarezdiez et al., PRETARGETED TUMOR IMAGING WITH STREPTAVIDIN IMMUNOCONJUGATES OF MONOCLONAL-ANTIBODY CC49 AND IN-111-DTPA-BIOCYTIN, Nuclear medicine and biology, 23(4), 1996, pp. 459-466
Citation: Rm. Reilly et J. Gariepy, INVESTIGATION OF FACTORS INFLUENCING THE SENSITIVITY OF TUMOR IMAGINGWITH PHANTOMS AND A RECEPTOR-BINDING RADIOPHARMACEUTICAL, The Journal of nuclear medicine, 37(5), 1996, pp. 911-911
Citation: S. Remy et al., A NEW RADIOLIGAND FOR THE EPIDERMAL GROWTH-FACTOR RECEPTOR - IN-111 LABELED HUMAN EPIDERMAL GROWTH-FACTOR DERIVATIZED WITH A BIFUNCTIONAL METAL-CHELATING PEPTIDE, Bioconjugate chemistry, 6(6), 1995, pp. 683-690
Citation: Wm. Ngai et al., IN-VITRO AND IN-VIVO EVALUATION OF STREPTAVIDIN IMMUNOCONJUGATES OF THE 2ND GENERATION TAG-72 MONOCLONAL ANTIBODY-CC49, Nuclear medicine and biology, 22(1), 1995, pp. 77-86
Authors:
SMITH AJ
REILLY RM
KIRSH JC
BONIFACE G
SCHMOCKER BJ
BURKES R
POLIHRONIS J
DAMANI MT
HAY K
SANDHU JS
GALLINGER S
STERN HS
Citation: Aj. Smith et al., TUMOR IMAGING AND PHARMACOKINETICS OF TC-99M LABELED MONOCLONAL-ANTIBODY 170H.82 IN PATIENTS WITH COLORECTAL-CANCER, Antibody immunoconjugates, and radiopharmaceuticals, 8(4), 1995, pp. 203-214
Authors:
REILLY RM
SANDHU J
ALVAREZDIEZ TM
GALLINGER S
KIRSH J
STERN H
Citation: Rm. Reilly et al., PROBLEMS OF DELIVERY OF MONOCLONAL-ANTIBODIES - PHARMACEUTICAL AND PHARMACOKINETIC SOLUTIONS, Clinical pharmacokinetics, 28(2), 1995, pp. 126-142
Authors:
MARKS A
BALLINGER JR
REILLY RM
LAW J
BAUMAL R
Citation: A. Marks et al., A NOVEL ANTI-SEMINOMA MONOCLONAL-ANTIBODY (M2A) LABELED WITH TC-99M -POTENTIAL APPLICATION FOR RADIOIMMUNOSCINTIGRAPHY, British Journal of Urology, 75(2), 1995, pp. 225-229
Authors:
CHAPMAN PB
GILLIES SD
HOUGHTON AN
REILLY RM
Citation: Pb. Chapman et al., MAPPING EFFECTOR FUNCTIONS OF A MONOCLONAL-ANTIBODY TO GD3 BY CHARACTERIZATION OF A MOUSE-HUMAN CHIMERIC ANTIBODY, Cancer immunology and immunotherapy, 39(3), 1994, pp. 198-204
Authors:
REILLY RM
NG K
POLIHRONIS J
SHPITZ B
NGAI WM
KIRSH JC
GALLINGER S
STERN H
Citation: Rm. Reilly et al., IMMUNOSCINTIGRAPHY OF HUMAN COLON-CANCER XENOGRAFTS IN NUDE-MICE USING A 2ND-GENERATION TAG-72 MONOCLONAL-ANTIBODY LABELED WITH (99)TC(M), Nuclear medicine communications, 15(5), 1994, pp. 379-387
Citation: Wm. Ngai et Rm. Reilly, A SIMPLE METHOD TO DETERMINE THE IMMUNOREACTIVITY OF RADIOLABELED MONOCLONAL-ANTIBODIES TO THE TAG-72 ANTIGEN, Applied radiation and isotopes, 44(9), 1993, pp. 1193-1197
Authors:
NGAI WM
REILLY RM
SHPITZ B
GALLINGER S
KIRSH J
STERN H
Citation: Wm. Ngai et al., PREPARATION OF STREPTAVIDIN (SA) IMMUNOCONJUGATES OF MONOCLONAL-ANTIBODY (MAB) CC49 FOR 2-STEP TARGETING OF COLON CANCER WITH IN-111 AND TC-99M BIOTIN, The Journal of nuclear medicine, 34(5), 1993, pp. 99-99
Citation: Rm. Reilly, IMMUNOSCINTIGRAPHY OF TUMORS USING TC-99(M)-LABELED MONOCLONAL-ANTIBODIES - A REVIEW, Nuclear medicine communications, 14(5), 1993, pp. 347-359